Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 USD | -2.50% | +2.75% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 199M |
---|---|---|---|---|---|
Net income 2024 * | -70M | Net income 2025 * | -96M | EV / Sales 2024 * | - |
Net cash position 2024 * | 30.75M | Net cash position 2025 * | 36.28M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.59
x | P/E ratio 2025 * |
-2.27
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.54% |
1 day | -2.50% | ||
1 week | +2.75% | ||
Current month | -1.75% | ||
1 month | -4.17% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 8.96 | -2.50% | 44,564 |
24-06-04 | 9.19 | +1.21% | 38,533 |
24-06-03 | 9.08 | -0.44% | 39,182 |
24-05-31 | 9.12 | +6.67% | 33,912 |
24-05-30 | 8.55 | -1.95% | 41,075 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 205M | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- BOLD Stock